Marion Mccourt - Net Worth and Insider Trading
Marion Mccourt Net Worth
The estimated net worth of Marion Mccourt is at least $13 Million dollars as of 2024-06-05. Marion Mccourt is the EVP Commercial of Regeneron Pharmaceuticals Inc and owns about 13,105 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $13 Million. Details can be seen in Marion Mccourt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marion Mccourt has not made any transactions after 2024-05-01 and currently still holds the listed stock(s).
Transaction Summary of Marion Mccourt
Marion Mccourt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marion Mccourt owns 5 companies in total, including Regeneron Pharmaceuticals Inc (REGN) , SCYNEXIS Inc (SCYX) , and CytomX Therapeutics Inc (CTMX) among others .
Click here to see the complete history of Marion Mccourt’s form 4 insider trades.
Insider Ownership Summary of Marion Mccourt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-05-01 | SVP Commercial |
| SCYX | SCYNEXIS Inc | 2017-04-03 | director |
| CTMX | CytomX Therapeutics Inc | 2017-03-29 | director |
 | | 2017-04-07 | Principal Operating Officer |
| | 2016-09-28 | Chief Operating Officer |
Marion Mccourt Latest Holdings Summary
Marion Mccourt currently owns a total of 1 stock. Marion Mccourt owns 13,105 shares of Regeneron Pharmaceuticals Inc (REGN) as of May 1, 2024, with a value of $13 Million.
Latest Holdings of Marion Mccourt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-05-01 | 13,105 | 993.29 | 13,017,065 |
Holding Weightings of Marion Mccourt
Marion Mccourt Form 4 Trading Tracker
According to the SEC Form 4 filings, Marion Mccourt has made a total of 32 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 32 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 250 shares on May 1, 2024, which brought Marion Mccourt around $222,352.
Insider Trading History of Marion Mccourt
- 1
Marion Mccourt Trading Performance
Marion Mccourt Ownership Network
Marion Mccourt Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Marion Mccourt is the SVP Commercial of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Gen Counsel & Secretary Joseph J Larosa , director & President & CEO Leonard S Schleifer , and director & President and CSO George Yancopoulos .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Marion Mccourt made 15 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 7,866. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 1,200 shares made by Arthur F Ryan , a net sale of 7,302 shares made by Bonnie L Bassler , and a net sale of 12,933 shares made by Michael S Brown .
In summary, during the past 3 months, insiders sold 118,291 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 118,291 shares. During the past 18 months, 294,990 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 294,990 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Marion Mccourt Mailing Address
Above is the net worth, insider trading, and ownership report for Marion Mccourt. You might contact Marion Mccourt via mailing address: C/o Axovant Sciences, Inc., 320 West 37th Street, 5th Floor, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
